Investor List:

Top Pharmaceuticals Series B Investors in Canada (5)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of James C. Murray, Partner at ExSight Capital Management
James C. Murray
Sweet spot: $1M
Range: $200K - $4.0M
Investors in Europe, Investors in Canada, Investors in United States
Investors in Medical Devices (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Robotics (Pre-seed), Investors in Hardware (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in Therapeutics (Pre-seed), Investors in Drug Delivery (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Medical Devices (Pre-seed), Investors in Hardware (Pre-seed), Investors in Robotics (Pre-seed), Investors in Digital Health (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in BioTech (Pre-seed), Investors in Drug Delivery (Seed), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Health & Hospital Services (Seed), Investors in Digital Health (Seed), Investors in Diagnostics (Seed), Investors in Therapeutics (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Drug Delivery (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Hardware (Seed), Investors in Robotics (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in Digital Health (Series A), Investors in Medical Devices (Series A), Investors in Drug Delivery (Series A), Investors in Hardware (Series A), Investors in Therapeutics (Series A), Investors in Diagnostics (Series A), Investors in Health & Hospital Services (Series A), Investors in Therapeutics (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Drug Delivery (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Hardware (Series A), Investors in Robotics (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Therapeutics (Series B), Investors in Hardware (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series B), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Health & Hospital Services (Series B), Investors in Diagnostics (Series B), Investors in BioTech (Series B), Investors in Robotics (Series B), Investors in Therapeutics (Series B), Investors in Drug Delivery (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Hardware (Series B), Investors in Robotics (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Canada (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in New York City (Other Lists)
Photo of Xinhong Lim, Managing Director at Vickers Venture Partners
Xinhong Lim
Vickers Venture Partners·Managing Director
Sweet spot: $5.0M
Range: $3.0M - $10.0M
Investors in Singapore, Investors in United Kingdom, Investors in United States, Investors in China, Investors in Indonesia, Investors in Canada
Investors in Chemicals (Series A), Investors in Semiconductors (Series A), Investors in Pharmaceuticals (Series A), Investors in Material Science (Series A), Investors in Therapeutics (Series A), Investors in Medical Devices (Series A), Investors in EnergyTech (Series A), Investors in Therapeutics (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in Chemicals (Series A), Investors in AI (Series A), Investors in Material Science (Series A), Investors in Semiconductors (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in EnergyTech (Series A), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Material Science (Series B), Investors in Semiconductors (Series B), Investors in Chemicals (Series B), Investors in Pharmaceuticals (Series B), Investors in Therapeutics (Series B), Investors in Medical Devices (Series B), Investors in EnergyTech (Series B), Investors in BioTech (Series B), Investors in Therapeutics (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in Chemicals (Series B), Investors in AI (Series B), Investors in Material Science (Series B), Investors in Semiconductors (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in EnergyTech (Series B), Investors in ClimateTech/CleanTech (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Canada (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Eric Blondeel, Venture Partner at Pioneer Fund
Eric Blondeel
Pioneer Fund·Venture Partner
Sweet spot: $250K
Range: $200K - $300K
Investors in Canada
Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Seed), Investors in Medical Devices (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Canada (Other Lists)
TP
Thomas (Tianyu) Piao
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Canada
Photo of Humayun H., Investor
Humayun H.
Investor
Sweet spot: $1M
Range: $100K - $10.0M
Investors in LatAm (Latin America), Investors in Mexico, Investors in Canada, Investors in United States, Investors in Asia, Investors in Europe
Investors in Wellness & Fitness (Seed), Investors in Therapeutics (Seed), Investors in Pharmaceuticals (Seed), Investors in Robotics (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Robotics (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in Consumer Internet (Seed), Investors in BioTech (Seed), Investors in Real Estate/PropTech (Seed), Investors in AI (Seed), Investors in Digital Health (Seed), Investors in AI (Seed), Investors in Consumer Internet (Seed), Investors in Therapeutics (Seed), Investors in Wellness & Fitness (Seed), Investors in Robotics (Seed), Investors in Medical Devices (Seed), Investors in Real Estate/PropTech (Seed), Investors in BioTech (Seed), Investors in Digital Health (Seed), Investors in AI (Seed), Investors in Wellness & Fitness (Seed), Investors in Consumer Internet (Seed), Investors in Real Estate/PropTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Wellness & Fitness (Series A), Investors in Therapeutics (Series A), Investors in Wellness & Fitness (Series A), Investors in Robotics (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in Real Estate/PropTech (Series A), Investors in Consumer Internet (Series A), Investors in BioTech (Series A), Investors in Real Estate/PropTech (Series A), Investors in AI (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in Consumer Internet (Series A), Investors in Therapeutics (Series A), Investors in Wellness & Fitness (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Real Estate/PropTech (Series A), Investors in BioTech (Series A), Investors in Digital Health (Series A), Investors in AI (Series A), Investors in Consumer Internet (Series A), Investors in Robotics (Series A), Investors in Therapeutics (Series B), Investors in Wellness & Fitness (Series B), Investors in Therapeutics (Series B), Investors in Wellness & Fitness (Series B), Investors in Robotics (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in Real Estate/PropTech (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in AI (Series B), Investors in Consumer Internet (Series B), Investors in Real Estate/PropTech (Series B), Investors in Robotics (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in AI (Series B), Investors in Consumer Internet (Series B), Investors in Therapeutics (Series B), Investors in Wellness & Fitness (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Real Estate/PropTech (Series B), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Digital Health (Series B), Investors in Consumer Internet (Series B), Investors in Robotics (Series B), Investors in Canada (Other Lists), Investors in LatAm (Latin America) (Other Lists), Investors in London (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Angel, Scout, and Solo-Capitalists (Other Lists), Investors in Investors who invested in diverse founders (Other Lists)
Get new data & insights delivered to your inbox